Schonfeld Strategic Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Buy	+32,597	New	+$925K	﹤0.01%	1497
2022 Q2	–	Sell	-51,082	Closed	-$3.17M	–	2704
2022 Q1	$3.17M	Buy	51,082 +7,656	+18%	+$469K	0.03%	578
2021 Q4	$2.39M	Buy	+43,426	New	+$2.27M	0.02%	661
2021 Q3	–	Sell	-42,510	Closed	-$2.93M	–	2262
2021 Q2	$2.93M	Sell	42,510 -34,365	-45%	-$2.62M	0.03%	598
2021 Q1	$5.93M	Buy	76,875 +52,975	+222%	+$4.88M	0.07%	368
2020 Q4	$2.37M	Buy	23,900 +12,990	+119%	+$1.59M	0.03%	560
2020 Q3	$1.55M	Buy	+10,910	New	+$1.82M	0.03%	586
2016 Q4	–	Sell	-9,398	Closed	-$608K	–	589
2016 Q3	$608K	Buy	+9,398	New	+$530K	0.1%	247

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Schonfeld Strategic Advisors's LKFT Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 32,597 shares worth $977K. The stake represents ﹤0.01% of the portfolio and ranks #1497 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in LKFT as recently as Q1 2022.

Schonfeld Strategic Advisors first reported a position in LKFT in Q3 2016 and has held it in 8 quarters since. The position peaked at $5.93M in Q1 2021. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Schonfeld Strategic Advisors held 32,597 shares of Lakefront Biotherapeutics American Depositary Shares worth $977K as of Q2 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Schonfeld Strategic Advisors position in Q2 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1497 holding.
Schonfeld Strategic Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2016 and has held it in 8 quarters since.
Schonfeld Strategic Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.93M in Q1 2021.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.